Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 169

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Neuroprotective effects of estrogen upon the nigrostriatal dopaminergic system

Dluzen, Dean E. · 2000 · Journal of Neurocytology

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1023/a:1007117424491

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 134

  1. ALI, S. F. & FREYALDENHOVEN, T. (1999) MPTP-a model of parkinson's disease. In Chemicals and Neurodegenerative Disease (edited by BONDY, S. C.) pp. 160–188. Scottsdale, AZ: Prominent Press.
  2. ANDERSON, L. I., MC DERMOTT, J. L. & DLUZEN, D. E. (1999) Estrogen-tamoxifen interactions upon striatal dopaminergic neurotoxicity produced by MPTP. Neuroscience Abstracts 25, 2088.
  3. ARNAULD, E., DUFY, B., PESTRE, M. & VINCENT, J. D. (1981) Effects of estrogens on the responses of caudate neurons to microiontophoretically applied dopamine. Neuroscience Letters 21, 325–331. · doi:10.1016/0304-3940(81)90225-1
  4. ASTHANA, S., BAKER, L. D., CRAFT, S., RASKIND, M. A., AVERY, E., LOFGREEN, C. P., CHERRIER, M. & PLYMATE, S. R. (1999) Cognitive and neuroendocrine Estrogen and nigrostriatal neuroprotection 395 responses to estrogen in postmenopausal women with alzheimer's disease. Neuroscience Abstracts 25, 52.
  5. ATTALI, G., WEIZMAN, A., GIL-AD, I. & REHAVI, M. (1997) Opposite modulatory effects of ovarian hormones on rat brain dopamine and serotonin transporters. Brain Research 756, 153–159. · DOI
  6. AYRES, S., TANG, M. & SUBBIAH, M. T. (1996) Estradiol-17beta as an antioxidant: Some distinct features when compared with common fat-soluble antioxidants. Journal of Laboratory and Clinical Medicine 128, 367–375. · DOI
  7. BAKER, L. D., CRAFT, S., LOFGREEN, C., AVERY, E., RASKIND, M. A., CHERRIER, M., VEITH, R. C., PLYMATE, S. R. & ASTHANA, S. (1999) Dose-response estrogen-induced cognitive enhancements for postmenopausal women with Alzheimer's disease. Society for Neuroscience Abstracts 25, 53.
  8. BARBER, P. V., ARNOLD, A. G. & EVANS, G. (1976) Recurrent hormone dependent chorea: Effects of oestrogens and progesterones. Clinical Endocrinology 5, 291–293. · doi:10.1111/j.1365-2265.1976.tb01956.x
  9. BAZZETT, T. J. & BECKER, J. B. (1994) Sex differences in the rapid and acute effects of estrogen on striatal D2 dopamine receptor binding. Brain Research 637, 163–172. · DOI · Paper page
  10. BECKER, J. B. (1990) Direct effect of 17 beta-estradiol on striatum: Sex differences in dopamine release. Synapse 5, 157–164. · DOI · Paper page
  11. BECKER, J. B. (1999) Gender differences in dopaminergic function in striatum and nucleus accumbens. Pharmacology, Biochemistry and Behavior 64, 803–812. · DOI · Paper page
  12. BECKER, J. B. & BEER, M. E. (1986) The influence of estrogen on nigrostriatal dopamine activity: Behavioral and neurochemical evidence for both pre-and post-synaptic components. Behavioral Brain Research 19, 27–33. · DOI · Paper page
  13. BECKER, J. & RAMIREZ, V. D. (1981) Sex differences in the amphetamine stimulated release of catecholamines from rat striatal tissue in vitro. Brain Research 204, 361–372. · DOI · Paper page
  14. BECKER, J. B. & RUDICK, C. N. (1999) Rapid effects of estrogen or progesterone on the amphetamine-induced increase in striatal dopamine are enhanced by estrogen priming: A microdialysis study. Pharmacology, Biochemistry and Behavior 64, 53–57. · DOI · Paper page
  15. BEDARD, P. J., DI PAOLO, T., LANGELIER, P., POYET, P. & LABRIE, F. (1981) Behavioral and biochemical evidence of an effect of estradiol on striatal dopamine receptors. In Steroid Hormone Regulation of the Brain (edited by FUXE, K., GUSTAFSSON, J.-A. & WETTERBERG, L.) pp. 331–339. Oxford: Pergamon Press. · doi:10.1016/b978-0-08-026864-4.50031-1
  16. BEDARD, P. J., LANGELIER, P. & VILLENEUVE, A. (1977) Oestrogens and extrapyramidal system. Lancet 2, 1367–1368. · DOI · Paper page
  17. BEHL, C., SKUTELLA, T., LEZOUALC'H, F., POST, A., WIDMANN, M., NEWTON, C. J. & HOLSBOER, F. (1997) Neuroprotection against oxidative stress by estrogens: Structure-activity relationship. Molecular Pharmacology 51, 535–541. · DOI · Paper page
  18. BEHL, C., WIDMANN, M., TRAPP, T. & HOLSBOER, F. (1995) 17-B estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochemical and Biophysical Research Communications 216, 473–482. · DOI · Paper page
  19. BROOKS, W. J., JARVIS, M. F. & WAGNER, G. C. (1989) Influence of sex, age and strain on MPTP-induced neurotoxicity. Research Communications on Substance Abuse 10, 181–184.
  20. CARDINALI, D. P. & GOMEZ, E. (1977) Changes in hypothalamic noradrenaline, dopamine and serotonin uptake after oestradiol administration to rats. Journal of Endocrinology 73, 181–182. · DOI
  21. CARDINALI, D. P., RITTA, M. N., VACAS, M. I., LOWENSTEIN, P. R., GEJMAN, P. V., GONZALEZ-SOLVEYRA, C. & PEREYRA, E. (1982) Molecular aspects of neuroendocrine integrative processes in the pineal gland. In The pineal gland and its endocrine role (edited by AXELROD, J., FRASCHINI, F. & VELO, G. P.) pp. 199–219. New York: Plenum Press.
  22. CASS, W. A., ZAHNISER, N. R., FLACH, K. A. & GERHARDT, G. A. (1993) Clearance of exogenous dopamine in rat dorsal striatum and nucleus accumbens: Role of metabolism and effects of locally applied uptake inhibitors. Journal of Neurochemistry 61, 2269–2278. · DOI · Paper page
  23. CHIBA, K., TREVOR, A. J. & CASTAGNOLI, N. (1985) Active uptake of MPP+, a toxic metabolite of MPTP, by brain synaptosomes. Biochemistry and Biophysical Research Communications 128, 1228–1233. · DOI · Paper page
  24. CHAKRAVORTY, S. G. & HALBREICH, U. (1997) The influence of estrogen on monoamine oxidase activity. Psychopharmacological Bulletin 33, 229–233.
  25. CHEN, J. C. & RAMIREZ, V. D. (1988) Comparison of the effect of prolactin on the dopamine release from the rat dorsal and ventral striatum and from the mediobasal hypothalamus in vitro. European Journal of Pharmacology 149, 1–8. · doi:10.1016/0014-2999(88)90034-9
  26. CHEN, X. L., LI, R. & GUPTA, M. (1995) Estrogen may protect females from parkinson's disease. Society for Neuroscience Abstracts 21, 1252.
  27. CHEVILLARD, C., BARDEN, N. & SAAVEDRA, J. M. (1981) Estradiol treatment decreases typeA and increases type B monoamine oxidase in specific brain stem areas and cerebellum of ovariectomized rats. Brain Research 222, 177–181. · DOI
  28. CHIODO, L. A., CAGGIULA, A. R. & SALLER, C. F. (1981) Estrogen potentiates the stereotypy induced by dopamine agonists in the rat. Life Sciences 28, 827–835. · DOI
  29. CLARK, P. B. S. & REUBEN, M. (1995) Inhibition by dizocilpine (MK-801) of striatal dopamine release induced by MPTP and MPP+: Possible action at the dopamine transporter. British Journal of Pharmacology 114, 315–322. · DOI
  30. COSTA, M. M., REUS, V. I., WOLKOWITZ, O. M., MANFREDI, F. & LIEBERMAN, M. (1999) Estrogen replacement therapy and cognitive decline in memory impaired post-menopausal women. Biological Psychiatry 46, 182–188. · DOI
  31. CROWLEY, W. R., O'DONOHUE, T. L. & JACOBOWITZ, D. M. (1978) Sex differences in catecholamine content in discrete brain nuclei of the rat: Effects of neonatal castration or testosterone treatment. Acta Endocrinologica 89, 20–28.
  32. DEL ZOMPO, M., PICCARDI, M. P., RUIU, S., CORSINI, G. U. & VACCARI, A. (1992) Characterization of a putatively vesicular binding site for [3H]MPP+ in mouse striatal membranes. Brain Research 571, 354–357. · doi:10.1016/0006-8993(92)90677-2
  33. DICKO, A., MORISSETTE, M., AMEUR, S. B., PEZOLET, M. & DI PAOLO, T. (1999) Effect of estradiol and tamoxifen on brain membranes: Investigation by infrared and fluorescence spectroscopy. Brain Research Bulletin 49, 401–405. · DOI
  34. DI PAOLO, T. (1994) Modulation of brain dopamine transmission by sex steroids. Reviews in Neuroscience 5, 27–42. · DOI · Paper page
  35. DI PAOLO, T., DAIGLE, M. & LABRIE, F. (1984) Effect of estradiol and haloperidol on hypophysectomized rat brain dopamine receptors. Psychoneuroendocrinology 9, 399–404. · doi:10.1016/0306-4530(84)90047-7
  36. DI PAOLO, T., POYET, P. & LABRIE, F. (1982) Effect of prolactin and estradiol on rat striatal dopamine receptors. Life Sciences 31, 2921–2929. · DOI
  37. DI PAOLO, T., ROULLIARD, C. & BEDARD, P. (1985) 17B-estradiol at a physiological dose acutely increases dopamine turnover in rat brain. European Journal of Pharmacology 117, 197–203. · DOI · Paper page
  38. DISSHON, K. A., BOJA, J. W. & DLUZEN, D. E. (1998) Inhibition of striatal dopamine transporter activity by 17B-estradiol. European Journal of Pharmacology 345, 207–211. · DOI
  39. DISSHON, K. A. & DLUZEN, D. E. (1997) Estrogen as a modulator of MPTP-induced neurotoxicity: Effects upon corpus striatal dopamine release. Brain Research 764, 9–16. · DOI
  40. DISSHON, K. A. & DLUZEN, D. E. (1999a) Comparison of 17a-and 17B-estradiol upon striatal dopaminergic neurotoxicity produced by MPTP. Society for Neuroscience Abstracts 25, 2088.
  41. DISSHON, K. A. & DLUZEN, D. E. (1999b) Use of in vitro superfusion to assess the dynamics of striatal dopamine clearance: Influence of estrogen. Brain Research 842, 399–407. · DOI
  42. DISSHON, K. A. & DLUZEN, D. E. (2000) Estrogen reduces MPP+ acute striatal dopamine responses in vivo to the Neurotoxin in female, but not male rats. Brain Research 868, 95–104. · DOI
  43. DLUZEN, D. E. (1996) The effects of testosterone upon MPTP-induced neurotoxicity of the nigrostriatal dopaminergic system in male C57/Bl mice. Brain Research 715, 113–118. · DOI
  44. DLUZEN, D. E. (1997) Estrogen decreases corpus striatal neurotoxicity in response to 6-OHDA. Brain Research 767: 340–344. · DOI
  45. DLUZEN, D. E., DISSHON, K. A. & MC DERMOTT, J. L. (1998) Estrogen as a modulator of striatal dopaminergic neurotoxicity. In Recent Advances in Neurodegenerative Disorders (edited by MARWAH, J. & TIETELBAUM, H.) pp. 149–192. Scottsdale, AZ: Prominent Press.
  46. DLUZEN, D. E., LIU, B., CHEN, C.-Y. & DI CARLO, S. E. (1995) Daily spontaneous running alters behavioral and neurochemical indexes of nigrostriatal function. Journal of Applied Physiology 78, 1219–1224. · DOI
  47. DLUZEN, D. E. & MC DERMOTT, J. L. (2000) Neuroprotective role of estrogen upon methamphetamine and related neurotoxins within the nigrostriatal dopaminergic system. Annals of the New York Academy of Sciences 914, 112–126. · DOI
  48. DLUZEN, D. E., MC DERMOTT, J. L. & LIU, B. (1996a) Estrogen alters MPTP-induced neurotoxicity in female mice: Effects of striatal dopamine concentrations and release. Journal of Neurochemistry 66, 658–666. · DOI
  49. DLUZEN, D. E., MC DERMOTT, J. L. & LIU, B. (1996b) Estrogen as a neuroprotectant against MPTP-induced neurotoxicity in C57/Bl mice. Neurotoxicology and Teratology 18, 603–606. · DOI · Paper page
  50. ENERSBY, C. A. & WILSON, C. A. (1974) The effect of ovarian steroids on the accumulation of 3H-labelled monoamines by hypothalamic tissue in vitro. Brain Research 73, 321–331. · DOI
  51. EUVRARD, C., OBERLANDER, C. & BOISSIER, J. R. (1980) Antidopaminergic effect of estrogen at the striatal level. Journal of Pharmacology and Experimental Therapeutics 214, 179–185. · DOI
  52. FALARDEAU, P. & DI PAOLO, T. (1987) Regional effect of estradiol on rat caudate putamen dopamine receptors: Lateral-medial differences. Neuroscience Letters 74, 43–48. · DOI
  53. FERNANDEZ-RUIZ, J. J., AMOR, J. C. & RAMOS, J. A. (1989) Time-dependent effects of estradiol and progesterone on the number of striatal dopaminergic D2-receptors. Brain Research 476, 388–395. · DOI
  54. FERNANDEZ-RUIZ, J. J., DE MIGUEL, R., HERNANDEZ, M. L., CEBEIRA, M. & RAMOS, J. A. (1992) Comparisons between brain dopaminergic neurons of juvenile and aged rats: Sex-related differences. Mechanisms of Ageing and Development 63, 45–55. · DOI
  55. FIGLEWICZ, D. P. (1999) Endocrine regulation of neurotransmitter transporters. Epilepsy Research 37, 203–210. · DOI
  56. FREYALDENHOVEN, T. E., CADET, J. L. & ALI, S. F. (1996) The dopamine depleting effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in CD-1 mice are gender dependent. Brain Research 735, 232–238. · doi:10.1016/0006-8993(96)00598-7
  57. GAINETDINOV, R. R., FUMAGALLI, F., JONES, S. R. & CARON, M. G. (1997) Dopamine transporter is required for in vivo MPTP neurotoxicity: Evidence from mice lacking the transporter. Journal of Neurochemistry 69, 1322–1325. · DOI · Paper page
  58. GAMBOA, E. T., ISAACS, G. & HARTER, D. H. Chorea associated with oral contraceptive therapy. Archives of Neurology 25, 112–114. · doi:10.1001/archneur.1971.00490020030003
  59. GAO, X. & DLUZEN, D. E. (2000) Estrogen treatment protects, but does nor restore, nigrostriatal function in methamphetamine treated mice. The FASEB Journal 14, AI474.
  60. GIBBS, R. B. (1999) Treatment with estrogen and progesterone affects relative levels of brain derived neurotrophic factor mRNA and protein in different regions of the adult rat brain. Brain Research 844, 20–27. · DOI · Paper page
  61. GLAZER, W. M., NAFTOLIN, F., MOORE, D. C., BOWERS, M. B. & MAC LUSKY, N. J. (1983) The relationship of circulating estradiol to tardive dykinesia in men and postmenopausal women. Psychoneuroendocrinology 8, 429–434. · DOI
  62. GOLDMAN, H., SKELLEY, E. B., SANDMAN, C. A., CASTIN, A. J. & MURPHY, S. (1976) Hormones and regional blood flow. Pharmacology, Biochemistry and Behavior 5 (Suppl 1), 165–169. · DOI
  63. GOODMAN, Y., BRUCE, A. J., CHENG, B. & MATTSON, M. P. (1996) Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury and amyloid B-peptide toxicity in hippocampal neurons. Journal of Neurochemistry 66, 1836–1844. · DOI · Paper page
  64. GORDON, J. H. & PERRY, K. O. (1983) Pre-and postsynaptic neurochemical alteration following estrogen-induced striatal dopamine hypo-and hypersensitivity. Brain Research Bulletin 10, 425–428. · DOI
  65. GRAHAM, D. G. (1984) Catecholamine toxicity: A proposal for the molecular pathogenesis of manganese neurotoxicity and Parkinson's disease. Neurotoxicity 5, 83–95.
  66. GRANDBOIS, M., TANGUAY, B. & DI PAOLO, T. (1999) Estradiol and dehydroepiandrosterone but not dihydrotestosterone protect against MPTP-induced dopamine depletion in mice. Society for Neuroscience Abstracts 25, 1595.
  67. GREEN, P. S., BISHOP, J. & SIMPKINS, J. W. (1997) 17a-estradiol exerts neuroprotective effects on SK-N-SH cells. Journal of Neuroscience 17, 511–515. · DOI · Paper page
  68. GREEN, P. S., GRIDLEY, K. E. & SIMPKINS, J. W. (1996) Estradiol protects against B-amyloid (25–35)-induced toxicity in SK-N-SH human neuroblastoma cells. Neuroscience Letters 218, 165–168. · DOI · Paper page
  69. HASHIMOTO, M., HOSSAIN, S. & MASUMURA, S. (1999) Effect of aging on plasma membrane fluidity of rat aortic endothelial cells. Experimental Gerontology 34, 687–698. · DOI
  70. HEIKKILA, R. E., YOUNGSTER, S. K., MANZINO, L., CABBAT, F. S. & DUVOISIN, R. C. (1985). Effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropryridine and related compounds on the uptake of [3H]3,4dihydroxyphenylethylamine and [3H]5-hydroxytryptamine on neostriatal synaptosomal preparations. Journal of Neurochemistry 44, 310–313. · doi:10.1111/j.1471-4159.1985.tb07146.x
  71. HRUSKA, R. E., LUDMER, L. M. & SILBERGELD, E. K. (1980) Characterization of the striatal dopamine receptor supersensitivity produced by estrogen treatment of male rats. Neuropharmacology 19, 923–926. · DOI
  72. HUANG, A., SUN, D., KALEY, G. & KOLLER, A. (1997) Estrogen maintains nitric oxide synthesis in arterioles of female hypertensive rats. Hypertension 29, 1351–1356. · DOI
  73. JABER, M., JONES, S., GIROS, B. & CARON, M. G. (1997) The dopamine transporter: A crucial component regulating dopamine transmission. Movement Disorders 12, 629–633. · DOI · Paper page
  74. JAVITCH, J. A., D'AMATO, R. J., STRITTMATTER, S. M. & SYNDER, S. H. (1985) Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: Uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective neurotoxicity. Proceedings of the National Academy of Sciences of the USA 82, 2173–2177. · DOI · Paper page
  75. JIN, B. K., SHIN, D. Y., JEONG, MI, Y., GWAG MI, R., BAIK, H. W., YOON, K. S., CHO, Y. H., JOO, W. S., KIM, Y. S. & BAIK, H. H. (1998) Melatonin protects nigral dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP+) neurotoxicity in rats. Neuroscience Letters 245, 61–64. · DOI
  76. JONES, S. R., GAINETDINOV, R. R., JABER, M. M., GIROS, B., WIGHTMAN, R. M. & CARON, M. G. (1998) Profound neuronal plasticity in response to inactivation of the dopamine transporter. Proceedings of the National Academy of Sciences of the USA 95, 4029–4034. · DOI · Paper page
  77. JORDAN, V. G. & MORROW, M. (1999) Tamoxifen, raloxifene, and the prevention of breast cancer. Endocrine Reviews 20, 253–278.
  78. KLETZKY, O. A. & BORENSTEIN, R. (1987) Vasomotor instability of the menopause. In Menopause physiology and pharmacology (edited by MISHELL JR., D. R.) pp 53–65, Chicago: Year Book Medical Publishers Inc.
  79. KOLLER, W. C., BARR, A. & BIARY, N. (1982) Estrogen treatment of dyskinetic disorders. Neurology 32, 547–549. · DOI
  80. LAMMERS, C.-H., D'SOUZA, U., QIN, Z.-H., LEE, S.-H., YAJIMA, S. & MOURADIAN, M. M. (1999) Regulation of striatal dopamine receptors by estrogen. Synapse 34, 222–227. · DOI
  81. LEE, S.-H. & MOURADIAN, M. M. (1999) Up-regulation of D1A dopamine receptor gene transcription by estrogen. Molecular and Cellular Endocrinology 156, 151–157. · DOI
  82. LEIPHEIMER, R. E., ARVIN, M. A., FEDORKOVA, L., DISSHON, K. A. & DLUZEN, D. E. (1998) Estrogen modulation of MPP+-stimulated dopamine secretion in the corpus striatum of rats using in vivo and in vitro techniques. Society for Neuroscience Abstracts 24, 1723.
  83. LEVESQUE, D. & DI PAOLO, T. (1988) Rapid conversion of high into low striatal D2-dopamine receptor agonist binding sites after an acute physiological dose of 17B-estradiol. Neuroscience Letters 88, 113–118. · DOI
  84. LEVESQUE, D. & DI PAOLO, T. (1989) Chronic estradiol treatment increases ovariectomized rat striatal D-1 dopamine receptors. Life Sciences 45, 1813–1820. · DOI
  85. MAGYAR, K., SZENDE, B., LENGYEL, J., TARCZALI, J. & SZATMARY, I. (1998) The neuroprotective and neurorescue effects of (?)-deprenyl. Journal of Neural Transmission Suppl 52, 109–123. · DOI
  86. MARDER, K., TANG, M.-X., ALFARO, B., MEJIA, H., COTE, L., JACOBS, D., STERN, Y., SANO, M. & MAYEUX, M. (1998) Postmenopausal estrogen use and Parkinson's disease with and without dementia. Neurology 50, 1141–1143. · DOI
  87. MARSHALL, J. F., O'DELL, S. J. & WEIHMULLER, F. B. (1993) Dopamine-glutamate interactions in methamphetamine-induced neurotoxicity. Journal of Neural Transmission 91, 241–254. · DOI
  88. MC DERMOTT, J. L., KREUTZBERG, J. D., LIU, B. & DLUZEN, D. E. (1994a) Effects of estrogen treatment on sensorimotor task performance and brain dopamine concentrations in gonadectomized male and female CD-1 mice. Hormones and Behavior 28, 16–28. · DOI
  89. MC DERMOTT, J. L., LIU, B. & DLUZEN, D. E. (1994b) Sex differences and effects of estrogen on dopamine and DOPAC release from the striatum of male and female CD-1 mice. Experimental Neurology 125, 306–311. · DOI
  90. MC MILLAN, P. J., SINGER, C. A. & DORSA, D. M. (1996) The effect of ovariectomy and estrogen replacement on trkA and choline acetyltransferase mRNA expression in the basal forebrain of the adult female sprague dawley rat. Journal of Neuroscience 16, 1860–1865. · DOI · Paper page
  91. MICHEL, P. P. & HEFTI, F. (1990) Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture. Journal of Neuroscience Research 26, 428–435. · DOI · Paper page
  92. MICHEL, M. C., ROTHER, A., HIEMKE, C. & GHRAF, R. (1987) Inhibition of synaptosomal high-affinity uptake of dopamine and serotonin by estrogen agonists and antagonists. Biochemical Pharmacology 36, 3175–3180. · DOI
  93. MILLER, D. B. (1998) Endocrine disruption: Estrogen, androgen, and the nervous system. In Neurotoxicity (edited by TILSON, H. A. & HARRY, G. J.) pp. 201–218, Taylor & Francis.
  94. MILLER, D. B., ALI, S. F., O'CALLAGHAN, J. P. & LAWS, S. C. (1998) The impact of gender and estrogen on striatal dopamine neurotoxicity. Annals of the New York Academy of Sciences 844, 153–165. · DOI · Paper page
  95. MIRANDA, R. C. & SOHRABJI, F. (1996) Gonadal steroid receptors: Possible roles in the etiology and therapy of cognitive and neurological disorders. Annals of Reproductive Medicine and Chemistry 31, 11–20. · DOI
  96. MIURA, T., MURAOKA, S. & OGISO, T. (1996) Inhibition of lipid peroxidation by estradiol and 2-hydroxyestradiol. Steroids 61, 379–383. · doi:10.1016/0039-128x(96)00044-x
  97. MOOK-JUNG, I., JOO, I., SOHN, S., KWON, H. J., HUH, K. & JUNG, M. W. (1997) Estrogen blocks neurotoxic effects of B-amyloid (1–42) and induces neurite extension on B103 cells. Neuroscience Letters 235, 101–104. · DOI
  98. MOORADIAN, A. D. (1993) Antioxidant properties of steroids. Journal of Steroid Biochemistry 45, 509–511. · DOI · Paper page
  99. MORISSETTE, M., BIRON, D. & DI PAOLO, T. (1990) Effect of estradiol and progesterone on rat striatal uptake sites. Brain Research Bulletin 25, 419–422. · DOI
  100. MORISSETTE, M., GARCIA-SEGURA, L.-M., BELANGER, A. & DI PAOLO, T. (1992) Changes of rat striatal neuronal membrane morphology and steroid content during the estrous cycle. Neuroscience 49, 893–902. · DOI
  101. MOY, L. Y., ALBERS, D. S. & SONSALLA, P. K. (1998) Lowering ambient or core body temperature elevates striatal MPP+ levels and enhances toxicity to dopamine neurons in MPTP-treated mice. Brain Research 790, 264–269. · DOI
  102. NABULSI, A. A., FOLSON, A. R., WHITE, A., PATSCH, W., HEISS, G., WU, K. K. & SZKLO, M. (1993) Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. New England Journal of Medicine 328, 1069–1075. · DOI · Paper page
  103. NAKANO, M., SUGIOKA, K., NAITO, I., TAKEKOSHI, S. & NIKI, E. (1987) Novel and potent biological antioxidants on membrane phospholipid peroxidation: 2-hydroxy estrone and 2-hydroxy estradiol. Biochemical and Biophysical Research Communications 142, 919–924. · DOI
  104. O'DELL, S. J., WEIHMULLER, F. B. & MARSHALL, J. (1991) Multiple methamphetamine injections induce marked increases in extracellular striatal dopamine which correlate with subsequent neurotoxicity. Brain Research 564, 256–260. · DOI · Paper page
  105. OHKURA, T., TESHIMA, Y., ISSE, K., MATSUDA, H., INOUE, T., SAKAI, Y., IWASKI, N. & YAOI, Y. (1995) Estrogen increases cerebral and cerebellar blood flows in postmenopausal women. Menopause 2, 13–18.
  106. PASQUALINI, C., OLIVIER, V., GUIBERT, B., FRAIN, O. & LEVIEL, V. (1995) Acute stimulatory effect of estradiol on striatal dopamine synthesis. Journal of Neurochemistry 65, 1651–1657. · DOI · Paper page
  107. RIEDERER, P., KONRADI, C., SCHAY, V., KIENZL, E., BIRKMAYER, G., DANIELCZYK, W., SOFIL, E. & YOUDIM, M. B. H. (1986) Localization of MAO-A and MAO-B in human brain: A step in understanding the therapeutic actions of L-deprenyl. Advances in Neurology 45, 111–118.
  108. RUIZ-LARREA, M. B., LEAL, A. M., LIZA, M., LACORT, M. & DE GROOT, H. (1994) Antioxidant effects of estradiol and 2-hydroxyestradiol on iron-induced lipid peroxidation of rat liver microsomes. Steroids 59, 383–388. · DOI · Paper page
  109. RICAURTE, G. A., LANGSTON, J. W., DELANEY, L. E., IRWIN, I. & BROOKS, J. D. (1985) Dopamine uptake blockers protect against dopamine depleting effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse striatum. Neuroscience Letters 59, 259–264. · doi:10.1016/0304-3940(85)90141-7
  110. SANGHERA, M., MANAYE, K., MC MAHON, A., SONSALLA, P. K. & GERMAN, D. SC. (1997) Dopamine transporter mRNA levels are high in midbrain neurons vulnerable to MPTP. NeuroReport 8, 3327–3331. · DOI
  111. SANTIAGO, M., MACHARO, A. & CANO, J. (1994) Effect of L-arginine/nitric oxide pathway on MPP+-induced cell injury in the striatum of rats. British Journal of Pharmacology 111, 837–842. · DOI
  112. SATOH, N., YONEZAWA, A., TADANO, T., KISARA, K., ARAI, Y. & KINEMUCHI, H. (1987) Acute effects of a parkinsonism-inducing neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on mouse body temperature. Life Sciences 41, 1415–1424. · DOI
  113. SAUNDERS-PULLMAN, R., GORDON-ELLIOT, J., PARIDES, M., FAHN, S., SAUNDERS, H. R. & BRESSMAN, S. (1999) The effect of estrogen replacement on early parkinson's disease. Neurology 52, 1417–1421. · DOI · Paper page
  114. SAUTTER, J., MEYER, M., SPENCER, C., SEILER, R. W. & WIDMER, H. R. (1998) Effects of combined BDNF and GDNF treatment on cultured dopaminergic midbrain neurons. NeuroReport 9, 1093–1096. · DOI
  115. SCHWARTING, R. K. W. & HUSTON, J. P. (1996) Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae. Progress in Neurobiology 49, 215–266. · DOI · Paper page
  116. SINGER, C. A., PANG, P. A., DOBIE, D. J. & DORSA, D. M. (1996a) Estrogen increases GAP-43 (Neuromodulin) mRNAin preoptic area of aged rats. Neurobiology of Aging 17, 661–663. · doi:10.1016/0197-4580(96)00063-2
  117. SINGER, C. A., ROGERS, K. L., STRICKLAND, T. M. & DORSA, D. M. (1996b) Estrogen protects primary cortical neurons from glutamate toxicity. Neuroscience Letters 212, 13–16. · DOI · Paper page
  118. SINGH, M., MEYER, E. M. & SIMPKINS, J. W. (1995) The effect of ovariectomy and estradiol replacement on brain-derived neurotrophic factor messenger ribonucleic acid expression in cortical and hippocampal brain regions of female sprague dawley rats. Endocrinology 136, 2320–2324. · doi:10.1210/endo.136.5.7720680 · Paper page
  119. SPINA, M. B. & COHEN, G. (1989) Dopamine turnover and glutathione oxidation: Implications for parkinson's disease. Proceedings of the National Academy of Sciences of the USA 86, 1714–1718.
  120. STEPHENSON, J. (1999) Experts debate drugs for healthy women with breast cancer risk. Journal of the American Medical Association 282, 117–118. · doi:10.1001/jama.282.2.117
  121. THOMPSON, T. L. (1999) Attenuation of dopamine uptake in vivo following priming with estradiol benzoate. Brain Research 834, 164–167. · DOI
  122. TRANQUILLI, A. L., MAZZANTI, L., CUGINI, A. M., CESTER, N., GARZETTI, G. G. & ROMANINI, C. (1995) Transdermal estradiol and medroxyprogesterone acetate in hormone replacement therapy are both antioxidants. Gynecological Endocrinology 9, 137–141. · DOI
  123. TSAI, M. J. & LEE, E. H. Y. (1998) Nitric oxide donors protect cultured rat astrocytes from 1-methyl-4-phenylpyridinium-induce toxicity. Free Radical Biology and Medicine 24, 705–713. · DOI
  124. VACCARI, A. & BIASSONI, R. (1982) Gonadal influence on the inhibition of monoamine oxidase type B activity. Journal of Neuroscience Research 8, 13–19. · doi:10.1002/jnr.490080104
  125. VACCARI, A., DEL ZOMPO, M., MELIS, F., GESSA, G. L. & ROSSETTI, Z. L. (1991) Interactions of 1-methyl-4-phenylpyridinium ion and tyramine with a site putatively involved in the striatal vesicular release of dopamine. British Journal of Pharmacology 104, 573–574. · doi:10.1111/j.1476-5381.1991.tb12470.x
  126. VAN HARTESVELDT, C. & JOYCE, J. N. (1986) Effects of estrogen on the basal ganglia. Neuroscience & Biobehavioral Reviews 10, 1–14. · DOI · Paper page
  127. VAN HORNE, C., HOFFER, B. J., STROMBERT, I. & GERHARDT, G. A. (1992) Clearance and diffusion of locally applied dopamine in normal and 6-hydroxydopamine-lesioned rat striatum. Journal of Pharmacology and Experimental Therapeutics 263, 1285–1292. · DOI
  128. WAGNER, G. C., TEKIRIAN, T. L. & CHEO, C. T. (1993) Sexual differences in sensitivity to methamphetamine toxicity. Journal of Neural Transmission 93, 67–70. · DOI
  129. WEAVER, JR. C. E., PARK-CHUNG, M., GIBBS, T. T. & FARB, D. H. (1997) 17B-estradiol protects against NMDA-induced excitotoxicity by direct inhibition of NMDA receptors. Brain Research 761, 338–341. · DOI · Paper page
  130. WEIHMULLER, F. B., O'DELL, S. J. & MARSHALL, J. F. (1992) MK-801 protection against methamphetamine-induced striatal dopamine terminal injury is associated with attenuated dopamine overflow. Synapse 11, 155–163. · DOI
  131. WENGER, N. K., SPEROFF, L. & PACKARD, B. (1993) Cardiovascular health and disease in women. New England Journal of Medicine 329, 247–256. · DOI · Paper page
  132. WIRZ-JUSTICE, A., HACKMANN, E. & LICHTSTEINER, M. (1974) The effect of estradiol dipropionate and progesterone on monoamine uptake in rat brain. Journal of Neurochemistry 22, 187–189. · DOI
  133. YOUNGSTER, S. K., NICKLAS, W. J. & HEIKKILA, R. E. (1989) Structure-activity study of the mechanisms of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity II. Evaluation of the biological activity of the pyridinium metabolites formed from the monoamine oxidase-catalyzed oxidation of MPTP analogs. Journal of Pharmacology and Experimental Therapeutics 249, 829–835. · DOI
  134. YU, Y.-L. & WAGNER, G. C. (1994) Influence of gonadal hormones on sexual differences in sensitivity to methamphetamine-induced neurotoxicity. Journal of Neural Transmission 8, 215–221.

Cited by

Metadata

Authors
Dluzen, D. E.
Venue
Journal of Neurocytology
Published
2000-05
Volume
29
Issue
5-6
Pages
387-399
ISSN
  • 0300-4864 (ISSN-L)
  • 1573-7381
OpenAlex
W112387632
Cited by
169
References
2
FWCI
7.26
Type
journal article
Language
en
Open access
closed
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.